OPKO Health, Inc. (NASDAQ:OPK) has gained points at the start of Monday’s trading session and will be looking to continue on the momentum.
As of 11:49, OPK is trading at 3.71 up .06 gaining 1.7% on the day. The stock has a total volume of almost 1 million shares. The stock has moved in a range of $3.6950 – 3.8100 after opening at $3.71.
OPK Business Description
OPKO is a multinational biopharmaceutical and diagnostics company that is seeking to establish industry-leading positions in large, rapidly growing markets. It is based in Miami, Florida, and was incorporated in 1991.
OPK Latest Developments
OPKO Health, Inc. makes an announcement
- OPKO Health, Inc. announced today that it is transferring the licensed rights to RAYALDEE in Japan from Japan Tobacco Inc. (JT) to Vifor Fresenius Medical Care Renal Pharma (VFMCRP).
- JT notified OPKO Health of its decision to terminate the contract with OPKO’s subsidiary EirGen Pharma for the development and commercialization of RAYALDEE on 17th May 2021
|SHARES OUTSTANDING||670.16 M|
|SHARE FLOAT (%)||403.42 M (60.20%)|
|% HELD BY INSTITUTIONS||30.06|
Recent Stock Performance
|+/- EMA(20)||3.79 (-0.79%)|
|+/- SMA(50)||4.16 (-9.62%)|
|+/- SMA(200)||4.26 (-11.74%)|
|CCI20||-35.3615||Neutral||Chaikin Money Flow||-0.2941||Sell|
|MACD||-0.2031||Sell||Money Flow Index||33.4371||Buy|
|STOCH (14,3)||38.8235||Buy||STOCH RSI||0.9048||OverBought|